COVID19
Conditions
Brief summary
There is evidence that up to 30% of COVID-19 patients was reported with neurological manifestations such as impaired consciousness, headache, and dizziness have been reported in COVID-19 patients in addition, olfactory and taste alterations are common symptoms in patients affected by COVID-19.This study will be conducted to evaluate the effect of the novel coronavirus on audio-vestibular functions in confirmed COVID19 patients.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
\- Well educated patients Age: range between 20 to 50 years No previous history of hearing loss or otoneurologic disease Well confirmed COVID 19 patients: patients who were diagnosed with coronavirus from * symptoms: fever, cough, generalized malaise, dyspnea. * Laboratory finding: abnormalities have been observed in Complete blood count (CBC), high C-reactive protein and ferritin, elevated D-dimer. * Imaging: Chest CT scan: bilateral ground glass opacities, crazy paving, and consolidation. * nasopharyngeal swab for SARS-CoV-2 polymerase chain reaction testing (RT-PCR).
Exclusion criteria
* previous history of hearing loss or otoneurological disease
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Basic audiological evaluation: | 3 months after infection | Pure-tone audiometry. |
| Auditory evoked potentials: | 3 months after infection | Auditory brainstem response. |
| Auditory evoked potentials | 3 months after infection | P300 |
| Effect on vestibular functions | 3 months after infection | Videonystagmography |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Effect on cognitive functions | 3 months after infection | Cognitive function assessment: By Montreal test |
| Vestibular questionnaire | 3 months after infection | Dizziness Handicap Inventory (DHI). |
Countries
Egypt